Content about Atazanavir

June 29, 2012

Gilead seeks approval for HIV drug-boosting agent

Drug maker Gilead Sciences has submitted a regulatory approval application to the Food and Drug Administration for a drug designed to increase the blood levels of certain drugs for HIV.

May 14, 2012

FDA panel recommends approval for experimental Gilead HIV drug

A Food and Drug Administration expert panel has recommended approval of a drug made by Gilead Sciences for treating HIV, the drug maker said Friday.

December 20, 2011

WHO approves Mylan generic HIV drugs for use in developing world

The World Health Organization has approved three generic second-line treatments for HIV made by Mylan, the drug maker said Tuesday. The drugs will be delivered to people in developing countries living with HIV and AIDS.

December 2, 2011

Mylan generic drug for HIV/AIDS receives tentative FDA approval through PEPFAR

Under the President's Emergency Plan for AIDS Relief, the Food and Drug Administration has given tentative approval to a generic HIV and AIDS drug made by Mylan, the company said.

October 27, 2011

Bristol-Myers Squibb, Gilead Sciences to develop, commercialize HIV combo treatment

Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

October 4, 2010

Mylan subsidiary gets approval for HIV generic under PEPFAR

The Food and Drug Administration has approved a generic drug for HIV made by a...